
Coravog M 2mg/500mg/0.3mg Tablet
Marketer
Arlak Biotech Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Coravog M 2mg/500mg/0.3mg Tablet
Diabeglide-M 2mg/500mg/0.3mg tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Diabeglide-M should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are key to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat it. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Coravog M 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Coravog M 2mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Coravog M 2mg/500mg/0.3mg tablets on an empty stomach.
Common Side effects of Coravog M 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Coravog M 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Coravog M 2mg/500mg/0.3mg Tablet on an empty stomach.
How Coravog M 2mg/500mg/0.3mg Tablet works:
Each Coravog M tablet (2mg/500mg/0.3mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Coravog M 2mg/500mg/0.3mg tablets is dangerous.
PregnancyCONSULT YOUR DOCTOR
Use of Coravog M 2mg/500mg/0.3mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Coravog M 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Coravog M 2mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Coravog M 2mg/500mg/0.3mg Tablets is contraindicated in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Coravog M 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a low dose; however, its use is contraindicated in those with severe hepatic dysfunction. Medical advice is recommended.
What if you forget to take Coravog M 2mg/500mg/0.3mg Tablet :
Should you forget a Coravog M 2mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Coravog M 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
